Dr. van Velkinburgh’s international biomedical research career and entrepreneurial successes in the science communication industry have given her a uniquely comprehensive understanding of the importance of effective, accurate and ethical communications. In addition to her PhD in Molecular Physiology & Biophysics from Vanderbilt University, she completed advanced education in Business Administration (major in Accounting) and has professional experience in Finance (specializing in strategic planning) and Small Business Entrepreneurship. Her research projects have been carried out in government, academic, for-profit and non-profit clinical and laboratory settings, providing broad perspectives into the various business and regulatory underpinnings of biomedical research. Her publication record in high impact peer-reviewed journals, such as Nature and Science Translational Medicine, reflect her expertise in a broad range of scientific disciplines, including infectious disease pathology and immune response, metabolic and neurological disorders, and global threats to human health.
To date, Dr. van Velkinburgh has edited and written over 70,000 pages of scientific manuscripts (human, animal and in vitro studies) for submission to peer-reviewed publications, grants, text book chapters, theses, posters and oral presentations, and IHC/GCP common technical documents for regulatory submissions (CSRs, protocols, ICFs, etc.). In addition, she has created 1000s of standard operating procedure documents, business strategy documents, instructions to authors guidelines, website and marketing/outreach content. Her clients have ranged from individual scientists in academia and biotech start-ups to entire departments in universities and international agencies, such as the World Health Organization. Her worldwide travels and international collaborations in Europe, the Middle East, North Africa and Asia have instilled a deep respect for the intricacies of international communication.
She is passionately dedicated to global outreach efforts to help non-native English speaking scientists and clinicians publish their data, so that their evidence-based conclusions can reach across national boundaries to promote human health and well-being worldwide.